Table 1 Intermolecular Heck reaction of chloride 19 (Scheme 4)
Method
Catalyst, Base, Solvent
Heating Method/◦C
Bath (85)c
Time/h
Product (Yield%)
A
B
Pd(t-Bu3P)2, aCs2CO3, NMP
Pd(t-Bu3P)2, aCs2CO3, NMP
Pd(t-Bu3P)2, aCy2NMe, NMP,
Pd(X-Phos)2, bK2CO3, DMA
6
17a,b (31)
19 (69)
17a,b (41)
20 (59)
17a,b (13)
19 (87)
17a,b (83)
MWI (85)d
1
C
D
MWI (85)d
1
MWI (100)d
0.5
a Preformed catalyst (0.2 eq.). b Catalyst formed in situ by addition of Pd(OAc)2 (0.10 equiv.) and X-Phos (0.20 eq.) to reaction mixture. c External mercury
thermometer in oil bath. d Internal infrared thermometer.
Mixtures of double-bond isomers 17a,b were quantitatively con-
verted to the thermodynamically more stable internal double-bond
isomer, 17b, upon reaction with RhCl3 in ethanol (Scheme 5).5a
Notes and references
1 (a) A. D. Patil, A. J. Freyer, L. Killmer, P. Offen, B. Carte, A. J. Jurewicz
and R. K. Johnson, Tetrahedron, 1997, 53, 5047–5060; (b) Y. F. Hallock,
Tetracycle 17b is a common intermediate with our previously
described total synthesis of ( )-frondosin B.3e It is converted
into ( )-frondosin B through a sequence of gem-dimethylation of
the ketone (Me2TiCl2), chemoselective hydrogenation of the D7,8
double-bond and cleavage of the methylphenyl ether. In its longest
linear sequence, 9 steps from 1,3-dimethoxybenzene, this synthesis
gives frondosin B in an overall 34% yield and 47% yield (8 steps)
from commercially available 9.
J. H. Cardellina II and M. R. Boyd, Nat. Prod. Lett., 1998, 11, 153–160.
2 (a) M. Seitz, B. DeWald, N. Gerber and M. Baggioni, J. Clin. Invest.,
1991, 87, 463–469; (b) B. R. Lane, K. L. Paul, J. Block, J. Andersson,
M. J. Coffey, R. M. Strieter and D. M. Markovitz, J. Virol., 2001, 75,
8195–8202; (c) T. Karashima, P. Sweeney, A. Kamat, S. Huang, S. J.
Kim, M. Bar-Eli, D. J. McConkey and C. P. Dinney, Clin. Cancer Res.,
2003, 9, 2786–2797; (d) Y. M. Zhu, S. J. Webster, D. Flower and P. J. Woll,
Br. J. Cancer, 2004, 91, 1970–1976; (e) B. M. Mian, C. P. Dinney, C. E.
Bermejo, P. Sweeney, C. Tellez, X. D. Yang, J. M. Gudas, D. J. McConkey
and M. Bar-Eli, Clin. Cancer Res., 2003, 9, 3167–3175; (f) D. J. Brat, A. C.
Bellail and E. G. Van-Meir, Neuro-Oncology, 2005, 7, 122–133.
3 (a) M. Inoue, A. J. Frontier and S. J. Danishefsky, Angew. Chem., Int.
Ed., 2000, 39, 761–764; (b) M. Inoue, M. W. Carson, A. J. Frontier and
S. J. Danishefsky, J. Am. Chem. Soc., 2001, 123, 1878–1889; (c) C. C.
Hughes and D. Trauner, Angew. Chem., Int. Ed., 2002, 41, 1569–1572;
(d) C. C. Hughes and D. Trauner, Tetrahedron, 2004, 60, 9675–9686;
(e) D. J. Kerr, A. C. Willis and B. L. Flynn, Org. Lett., 2004, 6, 457; (f) I.
Mart´ınez, P. E. Alford and T. V. Ovaska, Org. Lett., 2005, 7, 1133–1135;
(g) X. Li, R. E. Kyne and T. V. Ovaska, Org. Lett., 2006, 8, 5153; (h) X.
Li, R. E. Kyne and T. V. Ovaska, Tetrahedron, 2007, 63, 1899–1906;
(i) B. M. Trost, Y. Hu and D. M. Horne, J. Am. Chem. Soc., 2007, 129,
11781–11790; (j) X. Li and T. V. Ovaska, Org. Lett., 2007, 9, 3837–3840;
(k) G. Mehta and N. S. Likhite, Tetrahedron Lett., 2008, 49, 7113–7116.
4 The absolute stereochemistry depicted for (+)-frondosins is tentatively
depicted as (S)- based on previous asymmetric synthesis efforts, see ref.
3i,j and references cited therein.
Scheme 5 Formal synthesis of ( )-frondosin B.
5 (a) K.-S. Masters and B. L. Flynn, J. Org. Chem., 2008, 73, 8081–8084;
(b) K.-S. Masters and B. L. Flynn, Adv. Synth. Catal., 2009, 351, 530–
536.
6 For a previous report of benzo[b]furan-3-yl-triflates see: C. Morice, F.
Garrido, A. Mann and J. Suffert, Synlett, 2002, 501–503.
7 For previous reports on the application of MWI to Heck reactions see:
(a) G. K. Datta, K. S. A. Vallin and M. Larhed, Mol. Diversity, 2003,
7, 107; (b) B. M. Choudary, S. Madhi, N. S. Chowdari, M. L. Kantam
and B. Sreedhar, J. Am. Chem. Soc., 2002, 124, 14127; (c) K. Dahle´n,
E. A. A. Walle´n, M. Grøtli and K. Luthman, J. Org. Chem., 2006, 71,
6863.
8 Fu has previously described accumulation of HPdCl(t-Bu3P)2 in the
Heck reaction of alkenyl chlorides with Cs2CO3 where the Pd-hydride
becomes the resting-state in the catalytic cycle; (a) I. D. Hills and G. C.
Fu, J. Am. Chem. Soc., 2004, 126, 13178–9; (b) A. F. Littke and G. C.
Fu, J. Org. Chem., 1999, 64, 10–11.
In conclusion, an efficient synthesis of ( )-frondosin B has been
achieved that utilises functional-group tolerant Stille and Heck
reaction protocols as key steps, providing an excellent opportunity
to explore different substituents and ring sizes in SAR studies of
the frondosins. The capacity to access both double isomers, 17a
and 17b, in this synthesis will improve our chances of achieving
an enantioselective hydrogenation using chiral catalysts, which is
currently under investigation. Furthermore, the preparation of the
2-chlorobenzo[b]furan-1-yl triflates and the selective substitution
of its OTf and Cl moieties using palladium catalysis is likely
to have broad applicability in the preparation of other 2,3-
disubstituted benzo[b]furans. In particular, the combination of
MWI and X-Phos ligands in promoting palladium mediated
reactions of aryl/alkenyl chlorides is also likely to find broader
applicability.
9 (a) D. Garc´ıa-Cuadrado, A. A. C. Braga, F. Maseras and A. M.
Echavarren, J. Am. Chem. Soc., 2006, 128, 1066; (b) J.-P. Ebran, H. L.
Hansen, T. M. Ggsig and T. Skrydstrup, J. Am. Chem. Soc., 2007, 129,
6931.
1292 | Org. Biomol. Chem., 2010, 8, 1290–1292
This journal is
The Royal Society of Chemistry 2010
©